Details for New Drug Application (NDA): 074251

NDA 074251 describes CIMETIDINE HYDROCHLORIDE, which is a drug marketed by Cosette, Endo Operations, Hospira, Luitpold, Teva Parenteral, Ani Pharms, Chartwell Molecular, Cycle, G And W Labs Inc, Pai Holdings Pharm, Pharm Assoc, and Pharmobedient Cnsltg, and is included in twenty-one NDAs. It is available from one supplier. Additional details are available on the CIMETIDINE HYDROCHLORIDE profile page.

The generic ingredient in CIMETIDINE HYDROCHLORIDE is cimetidine hydrochloride. There are twenty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cimetidine hydrochloride profile page.

Summary for 074251

Tradename:	CIMETIDINE HYDROCHLORIDE
Applicant:	Chartwell Molecular
Ingredient:	cimetidine hydrochloride
Patents:	0

Pharmacology for NDA: 074251

Mechanism of Action

Histamine H2 Receptor Antagonists

Suppliers and Packaging for NDA: 074251

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
CIMETIDINE HYDROCHLORIDE	cimetidine hydrochloride	SOLUTION;ORAL	074251	ANDA	Chartwell RX, LLC	62135-809	62135-809-24	2 TRAY in 1 BOX (62135-809-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (62135-809-05)
CIMETIDINE HYDROCHLORIDE	cimetidine hydrochloride	SOLUTION;ORAL	074251	ANDA	Chartwell RX, LLC	62135-809	62135-809-37	237 mL in 1 BOTTLE (62135-809-37)

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	SOLUTION;ORAL			Strength	EQ 300MG BASE/5ML
Approval Date:	Dec 22, 1994	TE:		RLD:	No

Complete Access Available with Subscription